Dimebom is a new pharmaceutical treatment alternative for patients suffering from Alzheimer’s Disease. Dimebon is an older medication that has recently been discovered to be most helpful in treating patients with Alzheimer’s disease. Dimebom (the actual drug is known chemically as Dimebolin) is an older Russian antihistamine drug. It was popularly used in Russia as an antihistamine for hayfever, allergies and the like. In fact the drug was sold as an easy to obtain antihistamine – sold over the counter without a prescription.
Dimebom is currently in clinical trials in the United States by a company named Medivation . The website for Medivation, the pharmaceutical company involved with the clinical development and testing of Dimebom in the United States? Can be found at link www.medivation.com . To learn more about Medivation’s clinical trials of Dimebom the link is
http://www.medivation.com/pipeline_dimebontrials.html#p3
For more information on CONNECTION study locations, eligibility and enrollment, please visit www.connectionstudy.com or call toll-free 1-877-888-6386
At this point in time Dimebom is not available in any manner to Alzheimer Patients or their families, outside of the study material afforded by the Medivation Company and the Medivation clinical trials themselves.
http://www.dimebonalzheimers.com
